CPD Courses

Urology eLearning Workshop; A guide to NMIBC - Module 3 – NMIBC evidence based guidelines

Online Course medac Pharma

About the CPD course

This is the third module of an eLearning course which features 6 interactive modules; covering a full range of topics within non-muscle invasive bladder cancer. When you finish this module; you should be able to describe the following for this condition; The role of bladder cancer guidelines in clinical practice; Basics of evidence-based guidelines development; Recommendations for NMIBC in the latest UK (NICE) guidelines on bladder cancer; How they compare to European (EAU; European Association of Urology) guidelines on NMIBC.

CPD Provider

medac Pharma

medac Pharma

medac Pharma

medac Pharma is a privately owned, pharmaceutical company specialising in the development, diagnosis and treatment of diseases within the key areas of oncology, urology, haematology and autoimmune. The company was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products from standard cancer chemotherapy to niche speciality medicines.

More CPD courses by medac Pharma

Healthcare & Medical

Urology eLearning Workshop; A guide to NMIBC - Mod...

medac Pharma

This is the first module of an eLearning course which features 6 interactive modules; covering a ful...
Online Course
Healthcare & Medical

Urology eLearning Workshop; A guide to NMIBC - Mod...

medac Pharma

This is the second module of an eLearning course which features 6 interactive modules; covering a fu...
Online Course
Healthcare & Medical

Urology eLearning Workshop; A guide to NMIBC - Mod...

medac Pharma

This is the fourth module of an eLearning course which features 6 interactive modules; covering a fu...
Online Course
Healthcare & Medical

Urology eLearning Workshop; A guide to NMIBC - Mod...

medac Pharma

This is the fifth module of an eLearning course which features 6 interactive modules; covering a ful...
Online Course

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy